Tatsuo Kagimura

Foundation for Biomedical Research and Innovation

MedicinePsychologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Long-term adjuvant therapy for high-risk gastrointestinal stromal tumors in the real world”.

Long-term adjuvant therapy for high-risk gastrointestinal stromal tumors in the real world

Gastric Cancer(2022)10.1007/s10120-022-01310-z

N/A

0DataRank · unranked

25 citations

Shinsuke Sato, Masato Ozaka, Yujiro Nakahara, Yoshito Komatsu, Masato Kondo +7 more

Progression free survival (PFS) as a surrogate endpoint for overall survival (OS) in first-line advanced ovarian cancer (AOC) therapy: A Gynecologic Cancer InterGroup individual (GCIG) patient-level (IPD) analysis of multiple randomized trials.

Journal of Clinical Oncology(2018)10.1200/jco.2018.36.15_suppl.5576

N/A

0DataRank · unranked

0 citations

Liz-Anne Lewsley, Gennaro Daniele, Adrian David Cook, Nozomu Yanaihara, Anna Tinker +14 more